Adi Idris
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Molecular Biology top 5%
- Inflammasome and immune disorders
- RNA Interference and Gene Delivery
- Heme Oxygenase-1 and Carbon Monoxide
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 6
- Immunology 19
- interferon and immune responses 12
- Immunotherapy and Immune Responses 5
- Co-authors
- Katryn J. Stacey (4 shared papers)Tara L. Roberts (2 shared papers)Nigel A.J. McMillan (27 shared papers)Matthew J. Sweet (3 shared papers)Valérie Garceau (2 shared papers)David Hume (2 shared papers)Ian L. Ross (1 shared paper)Samantha Hodgson (1 shared paper)
In The Last Decade
Adi Idris
75 papers receiving 2.6k citations
Adi Idris's Hit Papers
Peers
Comparison fields: 5 of 129
- Immunology 1.1k
- Molecular Biology 1.4k
- Endocrinology 92
- Infectious Diseases 271
- Molecular Medicine 67
Countries citing papers authored by Adi Idris
This map shows the geographic impact of Adi Idris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Idris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Idris more than expected).
Fields of papers citing papers by Adi Idris
This network shows the impact of papers produced by Adi Idris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Idris. The network helps show where Adi Idris may publish in the future.
Co-authors
The 25 scholars most cited alongside Adi Idris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA Hit paper breakdown → | 2009 | 686 |
| 2 | AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC Hit paper breakdown → | 2013 | 424 |
| 3 | 2021 | 127 | |
| 4 | 2012 | 110 | |
| 5 | 2011 | 89 | |
| 6 | 2014 | 86 | |
| 7 | 2015 | 72 | |
| 8 | 2018 | 68 | |
| 9 | 2015 | 56 | |
| 10 | 2019 | 54 | |
| 11 | 2016 | 52 | |
| 12 | 2017 | 46 | |
| 13 | 2020 | 43 | |
| 14 | 2020 | 39 | |
| 15 | 2016 | 39 | |
| 16 | 2022 | 34 | |
| 17 | 2017 | 34 | |
| 18 | 2021 | 33 | |
| 19 | 2015 | 31 | |
| 20 | 2016 | 30 |
About Adi Idris
Adi Idris is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Epidemiology and Oncology, having authored 80 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), interferon and immune responses (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Cancer-related Molecular Pathways (6 papers), Viral Infections and Vectors (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Immunology (1.1k citations), Molecular Biology (1.4k citations), Endocrinology (92 citations), Infectious Diseases (271 citations) and Molecular Medicine (67 citations). Adi Idris has collaborated with scholars based in Australia, Brunei and China. Frequent co-authors include Katryn J. Stacey, Tara L. Roberts, Nigel A.J. McMillan, Matthew J. Sweet, Valérie Garceau, David Hume, Ian L. Ross, Samantha Hodgson, Greg Kelly and Jasmyn A. Dunn. Their work appears in journals such as Frontiers in Microbiology, PLoS ONE, Veterinary Microbiology, International Journal of Nanomedicine and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.